The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 25, 2017
Filed:
Sep. 01, 2015
Applicant:
Daiichi Sankyo Company, Limited, Tokyo, JP;
Inventors:
Taro Kanamaru, Tokyo, JP;
Shinichiro Tajiri, Tokyo, JP;
Sachiko Fukui, Tokyo, JP;
Kazuhiro Yoshida, Tokyo, JP;
Assignee:
DAIICHI SANKYO COMPANY, LIMITED, Tokyo, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 9/50 (2006.01); A61K 47/38 (2006.01); A61K 9/70 (2006.01); A61K 31/403 (2006.01); A61K 31/4745 (2006.01); A61K 31/437 (2006.01); A61K 31/522 (2006.01);
U.S. Cl.
CPC ...
A61K 9/2054 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2077 (2013.01); A61K 9/5047 (2013.01); A61K 9/7007 (2013.01); A61K 31/403 (2013.01); A61K 31/437 (2013.01); A61K 31/4745 (2013.01); A61K 31/522 (2013.01);
Abstract
It is intended to avoid dose dumping of a drug and improve the dissolution properties of the drug in the lower gastrointestinal tract, and thereby provide a sustained-release matrix preparation for oral administration that reliably exhibits its main pharmacological effect when orally administered once or twice a day. The present invention provides a sustained-release matrix preparation comprising (A) a pharmacologically active drug, (B) a combination of cellulose derivatives, and (C) mannitol.